Diacylglycerol kinase zeta deficiency attenuates papain-induced type 2 airway inflammation
Copyright © 2023 Elsevier Inc. All rights reserved..
Allergic airway diseases are caused by inappropriate immune responses directed against inhaled environmental antigens. We previously reported that the inhibition of diacylglycerol (DAG) kinaseζ (DGKζ),an enzyme that terminates DAG-mediated signaling,protects against T cell-mediated allergic airway inflammation by blocking Th2 cell differentiation.In this study, we tested whether DGKζ deficiency also affects allergic airway disease mediated by type 2 innate lymphoid cells (ILC2)s. DGKζ-deficient mice displayed diminished ILC2 function and reduced papain-induced airway inflammation compared to wildtype mice. Unexpectedly, however, mice with hematopoietic cell-specific deletion ofDGKζ displayed intact airway inflammation upon papain challenge. Rather, bone marrow chimera studies revealed thatDGKζ deficiency in the non-hematopoietic compartment was responsible for the reduction in papain-induced airway inflammation. These data suggest that DGK might represent a novel therapeutic target not only for T cell-dependent but also ILC2-dependent allergic airway inflammation by affecting non-hematopoietic cells.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:393-394 |
---|---|
Enthalten in: |
Cellular immunology - 393-394(2023) vom: 06. Nov., Seite 104780 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Singh, Brenal K [VerfasserIn] |
---|
Links: |
---|
Themen: |
DGKζ |
---|
Anmerkungen: |
Date Completed 06.12.2023 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.cellimm.2023.104780 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364099380 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364099380 | ||
003 | DE-627 | ||
005 | 20240321235552.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.cellimm.2023.104780 |2 doi | |
028 | 5 | 2 | |a pubmed24n1338.xml |
035 | |a (DE-627)NLM364099380 | ||
035 | |a (NLM)37918056 | ||
035 | |a (PII)S0008-8749(23)00119-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Singh, Brenal K |e verfasserin |4 aut | |
245 | 1 | 0 | |a Diacylglycerol kinase zeta deficiency attenuates papain-induced type 2 airway inflammation |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.12.2023 | ||
500 | |a Date Revised 20.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
520 | |a Allergic airway diseases are caused by inappropriate immune responses directed against inhaled environmental antigens. We previously reported that the inhibition of diacylglycerol (DAG) kinaseζ (DGKζ),an enzyme that terminates DAG-mediated signaling,protects against T cell-mediated allergic airway inflammation by blocking Th2 cell differentiation.In this study, we tested whether DGKζ deficiency also affects allergic airway disease mediated by type 2 innate lymphoid cells (ILC2)s. DGKζ-deficient mice displayed diminished ILC2 function and reduced papain-induced airway inflammation compared to wildtype mice. Unexpectedly, however, mice with hematopoietic cell-specific deletion ofDGKζ displayed intact airway inflammation upon papain challenge. Rather, bone marrow chimera studies revealed thatDGKζ deficiency in the non-hematopoietic compartment was responsible for the reduction in papain-induced airway inflammation. These data suggest that DGK might represent a novel therapeutic target not only for T cell-dependent but also ILC2-dependent allergic airway inflammation by affecting non-hematopoietic cells | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a DGKζ | |
650 | 4 | |a IL-33 | |
650 | 4 | |a ILC2 | |
650 | 4 | |a Lung | |
650 | 4 | |a Papain | |
650 | 4 | |a Type 2 inflammation | |
650 | 7 | |a Papain |2 NLM | |
650 | 7 | |a EC 3.4.22.2 |2 NLM | |
650 | 7 | |a Diacylglycerol Kinase |2 NLM | |
650 | 7 | |a EC 2.7.1.107 |2 NLM | |
700 | 1 | |a Yokoyama, Yuichi |e verfasserin |4 aut | |
700 | 1 | |a Tanaka, Yukinori |e verfasserin |4 aut | |
700 | 1 | |a Laczkó, Dorottya |e verfasserin |4 aut | |
700 | 1 | |a Deshpande, Deepak A |e verfasserin |4 aut | |
700 | 1 | |a Kambayashi, Taku |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cellular immunology |d 1970 |g 393-394(2023) vom: 06. Nov., Seite 104780 |w (DE-627)NLM000001821 |x 1090-2163 |7 nnns |
773 | 1 | 8 | |g volume:393-394 |g year:2023 |g day:06 |g month:11 |g pages:104780 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cellimm.2023.104780 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 393-394 |j 2023 |b 06 |c 11 |h 104780 |